Detalles de la búsqueda
1.
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
Breast Cancer Res Treat
; 199(3): 445-456, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043108
2.
Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1/PDL1.
J Autoimmun
; 136: 103013, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857863
3.
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
Int J Mol Sci
; 24(14)2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511057
4.
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.
Mod Pathol
; 35(8): 1066-1074, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177782
5.
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
Proc Natl Acad Sci U S A
; 116(9): 3604-3613, 2019 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733286
6.
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer.
Breast Cancer Res
; 23(1): 42, 2021 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785053
7.
Sinusoidal obstruction syndrome as a manifestation of acute antibody-mediated rejection after liver transplantation.
Am J Transplant
; 21(11): 3775-3779, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34008326
8.
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
Breast Cancer Res Treat
; 189(1): 111-120, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089119
9.
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Breast Cancer Res Treat
; 185(3): 657-666, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068198
10.
Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial.
Radiology
; 289(2): 317-324, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30129904
11.
Study of breast cancer incidence in patients of lymphangioleiomyomatosis.
Breast Cancer Res Treat
; 156(1): 195-201, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26951504
12.
Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.
Transpl Int
; 29(9): 1008-16, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27208691
13.
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
PLoS Biol
; 9(11): e1001199, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22110403
14.
Characteristics of women concordant and discordant for urine drug screens for cannabis exposure and self-reported cannabis use during pregnancy.
Neurotoxicol Teratol
; 103: 107351, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38604316
15.
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
Breast Cancer Res Treat
; 139(1): 87-93, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23576079
16.
The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel.
Cancers (Basel)
; 15(10)2023 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345053
17.
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.
Cancers (Basel)
; 15(3)2023 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765559
18.
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).
Front Oncol
; 13: 1184021, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37621686
19.
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.
EMBO Mol Med
; 15(4): e16715, 2023 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880458
20.
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice.
Breast Cancer Res Treat
; 134(3): 1161-8, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22772380